Learning Objectives:

1.  Review prognosis of High Grade B-cell Lymphoma and Double Expressor B-cell Lymphoma
2.  Discuss trial data for CAR T-cell therapy in the second line for aggressive B-cell lymphoma
3.  Recognize potential infectious complications of cellular therapy and their prevention

Session date: 
05/12/2022 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jennifer Cooperrider, MD